<DOC>
	<DOCNO>NCT01759290</DOCNO>
	<brief_summary>ABSORB FIRST prospective , multi-center registry . The objective study : - Provide ongoing post-market surveillance documentation safety , performance clinical outcome Absorb BVS ( Bioresorbable Vascular Scaffold ) System daily percutaneous coronary intervention ( PCI ) practice per Instructions Use ( IFU , on-label use ) . - To evaluate safety performance 12 mm short Absorb BVS single overlapping use ( bailout , optimization long lesion treatment ) treatment patient ischemic heart disease cause de novo native coronary artery lesion ( ) - Collect additional information ( e.g . acute success ) evaluate handle implantation Absorb BVS physician wide range commercial use condition follow routine clinical practice .</brief_summary>
	<brief_title>ABSORB FIRST Registry Designed Evaluate Safety Performance Absorb Bioresorbable Vascular Scaffold ( Absorb BVS ) Used Real-world Patients .</brief_title>
	<detailed_description>ABSORB FIRST Registry intend provide assessment safety performance Absorb BVS device accordance IFU real world use involve complex patient , lesion use ( example : long lesion , overlap use , bailout , patient high risk cardiac event , etc. ) . The ABSORB FIRST study register minimum 1800 patient approximately 90 site throughout multiple country worldwide Absorb BVS regulatory approval commercially available .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Coronary Occlusion</mesh_term>
	<criteria>The inclusion criterion must follow recent IFU may include limited following : Patient must least 18 year age time sign Informed Consent Form Patient treat de novo lesion locate previously untreated vessel . Patient must agree undergo require followup visit data collection . The exclusion criterion must follow recent IFU may include limited following : Inability obtain sign informed consent potential patient . Patient belongs vulnerable population ( per investigator 's judgment , also include people direct link ( hierarchical financial benefit ) registry Doctor registry Sponsor ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Angioplasty</keyword>
	<keyword>Bioabsorbable</keyword>
	<keyword>Bioresorbable</keyword>
	<keyword>BVS</keyword>
	<keyword>Coronary Artery Endothelial Responsiveness</keyword>
	<keyword>Coronary Scaffold</keyword>
	<keyword>Coronary Stent</keyword>
</DOC>